Cargando…

Comparison of treatment strategies for patients with limited-stage small cell lung cancer who received chemotherapy

BACKGROUND: The standard care for limited-stage small cell lung cancer (SCLC) is unclear. The purpose of this study is to compare the outcome for patients receiving chemotherapy alone, chemotherapy plus surgery (CS), chemotherapy plus radiation (CR), or chemotherapy plus surgery and radiation (CSR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Shenhai, Wei, Bo, Tian, Jintao, Song, Xiaoping, Wu, Bingqun, Hu, Pengcheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797666/ https://www.ncbi.nlm.nih.gov/pubmed/35117427 http://dx.doi.org/10.21037/tcr.2019.12.13

Ejemplares similares

Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database
por: Wei, Shenhai, et al.
Publicado: (2017)

Reconstruction of the Esophagus with Sternohyoid Flap after Resection of a Large Cervical Esophageal Leiomyosarcoma
por: Wei, Shenhai, et al.
Publicado: (2021)

Comprehensive analysis of prognostic predictors for patients with limited-stage small-cell lung cancer who underwent resection followed by adjuvant chemotherapy
por: Feng, Jian, et al.
Publicado: (2021)

Long Survival of a Small-Cell Lung Cancer Patient Who Received Maintenance Chemotherapy with Irinotecan
por: Yagi, Yoshitaka, et al.
Publicado: (2013)

Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer
por: Zhang, Jing, et al.
Publicado: (2017)

A study of the prognosis of patients with limited-stage small cell lung cancer who did or did not receive prophylactic cranial irradiation after effective chemoradiotherapy
por: Wu, Qing, et al.
Publicado: (2023)

Pegfilgrastim-Induced Aortitis in a Patient with Small-Cell Lung Cancer Who Received Immunotherapy Combined with Chemotherapy
por: Ito, Takanori, et al.
Publicado: (2023)

Clinical significance of miRNA - 106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy
por: Tian, Ye, et al.
Publicado: (2018)

The start of chemotherapy until the end of radiotherapy in patients with limited-stage small cell lung cancer
por: Lee, Kyoung Ju, et al.
Publicado: (2013)

The Clinical Implication of Conversion Surgery in Patients with Stage IV Gastric Cancer Who Received Systemic Chemotherapy
por: Shin, Min-Kyue, et al.
Publicado: (2023)

Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy
por: Omote, Norihito, et al.
Publicado: (2017)

Practice Patterns of Treatment Strategy of Limited-Stage Small-Cell Lung Cancer: Survey of Chinese Oncologists
por: Xu, Chang, et al.
Publicado: (2022)

Glasgow Prognostic Score in Patients Receiving Chemotherapy for Non-small-cell Lung Cancer in Stages IIIb and IV
por: Umihanic, Sefika, et al.
Publicado: (2014)

Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy
por: Goldschmidt, Jerome, et al.
Publicado: (2023)

Pathological complete response to radical surgery after receiving durvalumab plus neoadjuvant chemotherapy for 1 limited-stage small cell lung cancer patient: a case report
por: Li, Zhifeng, et al.
Publicado: (2022)

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer
por: Cheruvu, Praveena, et al.
Publicado: (2011)

Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?
por: Wang, Peng, et al.
Publicado: (2015)

Prognostic and Predictive Model for Stage II Colon Cancer Patients With Nonemergent Surgery: Who Should Receive Adjuvant Chemotherapy?
por: Zhang, Chun-Dong, et al.
Publicado: (2016)

The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy
por: Yeom, Seung-Seop, et al.
Publicado: (2020)

PDL-1 Expression and Survival in Metastatic Non-small Cell Lung Cancer Patients Who Received Chemotherapy as First-Line Treatment
por: Gürsoy, Pınar, et al.
Publicado: (2022)

One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer
por: Yu, Hao, et al.
Publicado: (2022)

Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis
por: Xu, Ya-Ping, et al.
Publicado: (2015)

Effectiveness and Safety of Anlotinib Monotherapy for Patients with Extensive-stage Small-Cell Lung Cancer Who Progressed to Chemotherapy: A Real-world Exploratory Study
por: Li, Yonghui, et al.
Publicado: (2022)

Surgery for limited stage small cell lung cancer
por: Gergen, Anna K., et al.
Publicado: (2020)

Influence of adverse effects of neoadjuvant chemoradiotherapy on the prognosis of patients with early-stage esophageal cancer (cT1b-cT2N0M0) based on the SEER database
por: Cao, Xiying, et al.
Publicado: (2023)

Analysis of thromboembolic events in patients with non-small cell lung cancer who received adjuvant chemotherapy: single-center real-world data
por: Kim, Tae-Hwan, et al.
Publicado: (2022)

Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: a retrospective cohort study
por: Lv, Zhihao, et al.
Publicado: (2021)

Assessment of Survival of Pediatric Patients With Hepatoblastoma Who Received Chemotherapy Following Liver Transplant or Liver Resection
por: Feng, Jincheng, et al.
Publicado: (2019)

Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer
por: Tu, Zegui, et al.
Publicado: (2021)

Comparison of once daily radiotherapy to 60 Gy and twice daily radiotherapy to 45 Gy for limited stage small-cell lung cancer
por: Han, Dan, et al.
Publicado: (2015)

Sequential chemotherapy followed by radical thoracic radiotherapy (50 Gy in 25 fractions) in limited stage small cell lung cancer
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2020)

Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer
por: Ma, Ning-Yi, et al.
Publicado: (2021)

Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy
por: Wang, Chao-Yang, et al.
Publicado: (2020)

Jumonji domain containing 5 is a potential prognostic indicator in non-small cell lung cancer patients who received platinum-based chemotherapy
por: Xiang, Xueping, et al.
Publicado: (2019)

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer
por: Sun, Bochen, et al.
Publicado: (2022)

Systemic therapy for limited stage small cell lung carcinoma
por: Noronha, Vanita, et al.
Publicado: (2020)

Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy
por: Wu, San-Gang, et al.
Publicado: (2015)

Meta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancer
por: Chen, Yuan-Yuan, et al.
Publicado: (2015)

The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy
por: Su, Po-Lan, et al.
Publicado: (2022)

Comparison Of Long Term Results Between Matched Chemoradiotherapy And Surgery For Limited Stage Small Cell Lung Cancer
por: Chen, Meng-yuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_va37tkp7kfs0r01n8f8690el6u